Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Isolation Sciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Isolation Sciences

Isolation Sciences

Seed

Isolation Sciences LLC: US-based developer and manufacturer of medical instruments for airborne and fume containment.

HQ
Williamsville, NY, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

Isolation Sciences LLC, founded with a mission to enhance safety and efficiency in laboratory environments, specializes in developing and manufacturing medical instruments aimed at containing airborne and fume contaminants. Their product line includes track systems, barrier films, and isolation units designed to minimize the escape of hazardous materials from fume hoods. The company primarily markets its innovative solutions within the United States, targeting energy managers and Environmental Health and Safety (EHS) directors who are focused on reducing energy costs and safety risks.

Notable figures affiliated with Isolation Sciences include industry experts in medical instrumentation and environmental safety. The company has achieved significant milestones in improving laboratory safety standards and reducing operational costs for their clients. Their impact is evident in the enhanced containment of hazardous materials, thereby protecting laboratory personnel and the environment from potential harm. Through their specialized products, Isolation Sciences continues to lead advancements in laboratory safety and efficiency.

Isolation Sciences - Quick Facts

When was Isolation Sciences founded?

Isolation Sciences was founded in 2005.

Where is Isolation Sciences' headquarters located?

Isolation Sciences' headquarters is located in Williamsville, NY, US.

When was Isolation Sciences' last funding round?

Isolation Sciences' most recent funding round was for $25k (USD) in August 2010.

How much has Isolation Sciences raised to-date?

As of Aug 1, 2010, Isolation Sciences has raised a total of $212k (USD).

How many employees does Isolation Sciences have?

Isolation Sciences has 30 employees as of Feb 4, 2024.

Isolation Sciences - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Automation
Geographic Exposure
  • United States
Model
  • Manufacturing
Revenue
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Medical Instruments
Tags
  • Cleantech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified